ID   GBP3_HUMAN              Reviewed;         595 AA.
AC   Q9H0R5; A2A317; A6NF86; B2RTW0; F8UW81; Q05D54; Q5T8L8; Q5T8L9; Q6P3V3;
AC   Q9NV33;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   20-JAN-2009, sequence version 3.
DT   28-JUN-2023, entry version 154.
DE   RecName: Full=Guanylate-binding protein 3;
DE            EC=3.6.5.- {ECO:0000250|UniProtKB:Q61107};
DE   AltName: Full=GTP-binding protein 3;
DE            Short=GBP-3;
DE   AltName: Full=Guanine nucleotide-binding protein 3;
GN   Name=GBP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, VARIANT TRP-225, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=22106366; DOI=10.1096/fj.11-189886;
RA   Nordmann A., Wixler L., Boergeling Y., Wixler V., Ludwig S.;
RT   "A new splice variant of the human guanylate-binding protein 3 mediates
RT   anti-influenza activity through inhibition of viral transcription and
RT   replication.";
RL   FASEB J. 26:1290-1300(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLN-221
RP   AND TRP-225.
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=17266443; DOI=10.1089/jir.2007.0086;
RA   Tripal P., Bauer M., Naschberger E., Mortinger T., Hohenadl C., Cornali E.,
RA   Thurau M., Sturzl M.;
RT   "Unique features of different members of the human guanylate-binding
RT   protein family.";
RL   J. Interferon Cytokine Res. 27:44-52(2007).
RN   [7]
RP   SUBCELLULAR LOCATION, AND DIMERIZATION.
RX   PubMed=21151871; DOI=10.1371/journal.pone.0014246;
RA   Britzen-Laurent N., Bauer M., Berton V., Fischer N., Syguda A.,
RA   Reipschlager S., Naschberger E., Herrmann C., Sturzl M.;
RT   "Intracellular trafficking of guanylate-binding proteins is regulated by
RT   heterodimerization in a hierarchical manner.";
RL   PLoS ONE 5:E14246-E14246(2010).
RN   [8]
RP   MUTAGENESIS OF LYS-105.
RX   PubMed=31216343; DOI=10.1371/journal.ppat.1007876;
RA   Ji C., Du S., Li P., Zhu Q., Yang X., Long C., Yu J., Shao F., Xiao J.;
RT   "Structural mechanism for guanylate-binding proteins (GBPs) targeting by
RT   the Shigella E3 ligase IpaH9.8.";
RL   PLoS Pathog. 15:e1007876-e1007876(2019).
CC   -!- FUNCTION: Interferon (IFN)-inducible GTPase that plays important roles
CC       in innate immunity against a diverse range of bacterial, viral and
CC       protozoan pathogens (PubMed:22106366). Hydrolyzes GTP very efficiently;
CC       GDP rather than GMP is the major reaction product (By similarity).
CC       Following infection, recruited to the pathogen-containing vacuoles or
CC       vacuole-escaped bacteria and acts as a positive regulator of
CC       inflammasome assembly by promoting the release of inflammasome ligands
CC       from bacteria (By similarity). Acts by promoting lysis of pathogen-
CC       containing vacuoles, releasing pathogens into the cytosol (By
CC       similarity). Following pathogen release in the cytosol, promotes
CC       recruitment of proteins that mediate bacterial cytolysis: this
CC       liberates ligands that are detected by inflammasomes, such as
CC       lipopolysaccharide (LPS) that activates the non-canonical CASP4/CASP11
CC       inflammasome or double-stranded DNA (dsDNA) that activates the AIM2
CC       inflammasome (By similarity). Exhibits antiviral activity against
CC       influenza virus (PubMed:22106366). {ECO:0000250|UniProtKB:Q61107,
CC       ECO:0000269|PubMed:22106366}.
CC   -!- FUNCTION: [Isoform 2]: Shows the most prominent antiviral activity in
CC       epithelial cells. {ECO:0000269|PubMed:22106366}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:Q61107};
CC   -!- SUBUNIT: Heterodimer with other family members, including GBP1, GBP2
CC       and GBP5 (PubMed:21151871). Dimerization regulates subcellular
CC       location. {ECO:0000269|PubMed:21151871}.
CC   -!- INTERACTION:
CC       Q9H0R5; P32455: GBP1; NbExp=3; IntAct=EBI-2798916, EBI-2869161;
CC       Q9H0R5; P32456: GBP2; NbExp=3; IntAct=EBI-2798916, EBI-714388;
CC       Q9H0R5; Q9H0R5: GBP3; NbExp=2; IntAct=EBI-2798916, EBI-2798916;
CC       Q9H0R5; Q96PP8: GBP5; NbExp=2; IntAct=EBI-2798916, EBI-749932;
CC       Q9H0R5; O95819: MAP4K4; NbExp=4; IntAct=EBI-2798916, EBI-2511133;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17266443}.
CC       Cytoplasm, perinuclear region {ECO:0000269|PubMed:21151871}. Golgi
CC       apparatus membrane {ECO:0000269|PubMed:21151871}. Note=Heterodimers
CC       with GBP1, GBP2 and GBP5 localize in the compartment of the prenylated
CC       GBPs: with GBP1 in a vesicle-like compartment, with GBP2, around the
CC       nucleus and with GBP5, at the Golgi apparatus.
CC       {ECO:0000269|PubMed:21151871}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H0R5-1; Sequence=Displayed;
CC       Name=2; Synonyms=GBP-3DeltaC;
CC         IsoId=Q9H0R5-4; Sequence=VSP_044360, VSP_044361;
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. GB1/RHD3 GTPase family. GB1 subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01052}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17992.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=CAB66615.1; Type=Miscellaneous discrepancy; Note=Unlikely isoform. Aberrant splice sites.; Evidence={ECO:0000305};
CC       Sequence=EAW73151.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JF927951; AEI54565.1; -; mRNA.
DR   EMBL; AL136680; CAB66615.1; ALT_SEQ; mRNA.
DR   EMBL; AL139416; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL160008; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW73151.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC017992; AAH17992.1; ALT_SEQ; mRNA.
DR   EMBL; BC140837; AAI40838.1; -; mRNA.
DR   CCDS; CCDS717.2; -. [Q9H0R5-1]
DR   RefSeq; NP_001306110.1; NM_001319181.1. [Q9H0R5-4]
DR   RefSeq; NP_060754.2; NM_018284.2. [Q9H0R5-1]
DR   AlphaFoldDB; Q9H0R5; -.
DR   SMR; Q9H0R5; -.
DR   BioGRID; 108905; 9.
DR   IntAct; Q9H0R5; 7.
DR   MINT; Q9H0R5; -.
DR   STRING; 9606.ENSP00000359512; -.
DR   iPTMnet; Q9H0R5; -.
DR   PhosphoSitePlus; Q9H0R5; -.
DR   BioMuta; GBP3; -.
DR   DMDM; 221222526; -.
DR   EPD; Q9H0R5; -.
DR   jPOST; Q9H0R5; -.
DR   MassIVE; Q9H0R5; -.
DR   MaxQB; Q9H0R5; -.
DR   PaxDb; Q9H0R5; -.
DR   PeptideAtlas; Q9H0R5; -.
DR   ProteomicsDB; 80318; -. [Q9H0R5-1]
DR   Antibodypedia; 51594; 161 antibodies from 27 providers.
DR   DNASU; 2635; -.
DR   Ensembl; ENST00000370481.9; ENSP00000359512.4; ENSG00000117226.12. [Q9H0R5-1]
DR   GeneID; 2635; -.
DR   KEGG; hsa:2635; -.
DR   MANE-Select; ENST00000370481.9; ENSP00000359512.4; NM_018284.3; NP_060754.2.
DR   UCSC; uc001dmt.4; human. [Q9H0R5-1]
DR   AGR; HGNC:4184; -.
DR   CTD; 2635; -.
DR   DisGeNET; 2635; -.
DR   GeneCards; GBP3; -.
DR   HGNC; HGNC:4184; GBP3.
DR   HPA; ENSG00000117226; Tissue enhanced (intestine).
DR   MIM; 600413; gene.
DR   neXtProt; NX_Q9H0R5; -.
DR   OpenTargets; ENSG00000117226; -.
DR   PharmGKB; PA28598; -.
DR   VEuPathDB; HostDB:ENSG00000117226; -.
DR   eggNOG; KOG2037; Eukaryota.
DR   GeneTree; ENSGT00940000164799; -.
DR   HOGENOM; CLU_018608_2_2_1; -.
DR   InParanoid; Q9H0R5; -.
DR   OMA; FDRPVDC; -.
DR   OrthoDB; 5309032at2759; -.
DR   PhylomeDB; Q9H0R5; -.
DR   TreeFam; TF331602; -.
DR   PathwayCommons; Q9H0R5; -.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SignaLink; Q9H0R5; -.
DR   BioGRID-ORCS; 2635; 14 hits in 1152 CRISPR screens.
DR   ChiTaRS; GBP3; human.
DR   GenomeRNAi; 2635; -.
DR   Pharos; Q9H0R5; Tbio.
DR   PRO; PR:Q9H0R5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9H0R5; protein.
DR   Bgee; ENSG00000117226; Expressed in ileal mucosa and 183 other tissues.
DR   ExpressionAtlas; Q9H0R5; baseline and differential.
DR   Genevisible; Q9H0R5; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005525; F:GTP binding; IBA:GO_Central.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB.
DR   GO; GO:0051715; P:cytolysis in another organism; ISS:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0140639; P:positive regulation of pyroptosis; ISS:UniProtKB.
DR   CDD; cd01851; GBP; 1.
DR   CDD; cd16269; GBP_C; 1.
DR   Gene3D; 1.20.1000.10; Guanylate-binding protein, C-terminal domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR030386; G_GB1_RHD3_dom.
DR   InterPro; IPR037684; GBP_C.
DR   InterPro; IPR003191; Guanylate-bd/ATL_C.
DR   InterPro; IPR036543; Guanylate-bd_C_sf.
DR   InterPro; IPR015894; Guanylate-bd_N.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10751; GUANYLATE BINDING PROTEIN; 1.
DR   PANTHER; PTHR10751:SF96; GUANYLATE-BINDING PROTEIN 3; 1.
DR   Pfam; PF02263; GBP; 1.
DR   Pfam; PF02841; GBP_C; 1.
DR   SUPFAM; SSF48340; Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51715; G_GB1_RHD3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiviral defense; Coiled coil; Cytoplasm;
KW   Golgi apparatus; GTP-binding; Hydrolase; Immunity; Innate immunity;
KW   Membrane; Nucleotide-binding; Reference proteome.
FT   CHAIN           1..595
FT                   /note="Guanylate-binding protein 3"
FT                   /id="PRO_0000261159"
FT   DOMAIN          35..276
FT                   /note="GB1/RHD3-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01052"
FT   REGION          1..309
FT                   /note="GTPase domain (Globular)"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   COILED          482..595
FT                   /evidence="ECO:0000255"
FT   BINDING         45..52
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   BINDING         67..69
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   BINDING         97..101
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   VAR_SEQ         357..383
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:22106366"
FT                   /id="VSP_044360"
FT   VAR_SEQ         554..595
FT                   /note="EQARVLKERCQGESTQLQNEIQKLQKTLKKKTKRYMSHKLKI -> VSKCIT
FT                   LWFVFLFSLCSS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:22106366"
FT                   /id="VSP_044361"
FT   VARIANT         221
FT                   /note="R -> Q (in dbSNP:rs4656078)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_054136"
FT   VARIANT         225
FT                   /note="R -> W (in dbSNP:rs4656077)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:22106366"
FT                   /id="VAR_054137"
FT   VARIANT         347
FT                   /note="T -> S (in dbSNP:rs3188433)"
FT                   /id="VAR_054138"
FT   VARIANT         469
FT                   /note="V -> M (in dbSNP:rs10493821)"
FT                   /id="VAR_029082"
FT   VARIANT         491
FT                   /note="C -> R (in dbSNP:rs17433780)"
FT                   /id="VAR_029083"
FT   VARIANT         558
FT                   /note="V -> A (in dbSNP:rs11808228)"
FT                   /id="VAR_029084"
FT   MUTAGEN         105
FT                   /note="K->E: Promotes ubiquitination and degradation by S.
FT                   flexneri IpaH9.8."
FT                   /evidence="ECO:0000269|PubMed:31216343"
FT   CONFLICT        271
FT                   /note="I -> T (in Ref. 5; AAH17992)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        290
FT                   /note="R -> C (in Ref. 1; CAB66615 and 4; AAI40838)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        334
FT                   /note="D -> G (in Ref. 5; AAH17992)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   595 AA;  68114 MW;  410A9BED9ABD2DDF CRC64;
     MAPEIHMTGP MCLIENTNGE LVANPEALKI LSAITQPVVV VAIVGLYRTG KSYLMNKLAG
     KNKGFSLGST VKSHTKGIWM WCVPHPKKPE HTLVLLDTEG LGDVKKGDNQ NDSWIFTLAV
     LLSSTLVYNS MGTINQQAMD QLYYVTELTH RIRSKSSPDE NENEDSADFV SFFPDFVWTL
     RDFSLDLEAD GQPLTPDEYL EYSLKLTQGT SQKDKNFNLP RLCIRKFFPK KKCFVFDLPI
     HRRKLAQLEK LQDEELDPEF VQQVADFCSY IFSNSKTKTL SGGIKVNGPR LESLVLTYIN
     AISRGDLPCM ENAVLALAQI ENSAAVQKAI AHYDQQMGQK VQLPAETLQE LLDLHRVSER
     EATEVYMKNS FKDVDHLFQK KLAAQLDKKR DDFCKQNQEA SSDRCSALLQ VIFSPLEEEV
     KAGIYSKPGG YCLFIQKLQD LEKKYYEEPR KGIQAEEILQ TYLKSKESVT DAILQTDQIL
     TEKEKEIEVE CVKAESAQAS AKMVEEMQIK YQQMMEEKEK SYQEHVKQLT EKMERERAQL
     LEEQEKTLTS KLQEQARVLK ERCQGESTQL QNEIQKLQKT LKKKTKRYMS HKLKI
//
